在宅薬物乱用検査市場- 世界の産業規模、シェア、動向、機会、予測、サンプルタイプ別、製品タイプ別、地域別、競争別、2020-2030F

在宅薬物乱用検査の世界市場は、2024年に6億7,595万米ドルとなり、予測期間中は2030年までCAGR5.01％で力強い成長が見込まれています。

同市場は、薬物乱用に対する意識の高まり、検査技術の継続的な進歩、目立たない自宅でのスクリーニング・オプションに対する需要の高まりによって急速に拡大しています。これらの自己管理型検査キットは、薬物使用を監視するための個人的で便利な方法をユーザーに提供し、臨床を受診する必要性を排除します。このようなソリューションに対する需要は、薬物検査における秘密保持を重視する個人の間で特に強いです。

市場はプラス成長を続けているもの、家庭用検査キットの精度と信頼性に関する懸念は依然として残っています。検査方法のばらつき、不適切なサンプル採取、限られた検出能力などの問題により、検査結果に一貫性がなくなり、偽陽性や偽陰性につながる可能性があります。こうした不正確さは、特にリハビリを受けている人や法的手続きに関与している人にとって、深刻な結果をもたらす可能性があります。これに対しメーカーは、家庭でのDOA検査の信頼性と有用性を高めるため、検査精度の向上、サンプル採取プロセスの改善、検出可能な物質の範囲の拡大に注力しています。

主な市場促進要因

主な市場課題：

主な市場動向：

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の在宅薬物乱用検査市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • サンプルの種類別（尿検査、唾液検査、血液検査など）
  • 製品タイプ別（薬物検査キット、ストリップ/ディップカード、カセット、カップなど）
  • 地域別（北米、欧州、アジア太平洋、南米、中東・アフリカ）
  • 企業別（2024）
• 市場マップ
• サンプルタイプ別
• 製品タイプ別
• 地域別

第6章 北米の在宅薬物乱用検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の在宅薬物乱用検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の在宅薬物乱用検査市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の在宅薬物乱用検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの在宅薬物乱用検査市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 世界の在宅薬物乱用検査市場：SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Abbott Laboratories Inc.
• Dragerwerk AG & Co. KGaA.
• UCP Biosciences Inc.
• Orient New Life Medical Co. Ltd.
• Assure Tech.（Hangzhou）Co., LTD
• Psychemedics Corporation
• Confirm Biosciences Inc
• Pharmatech Inc.
• Atlas Medical GmbH
• Home Health（U.K.）Ltd.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global At-Home Drug of Abuse Testing Market was valued at USD 675.95 million in 2024 and is expected to experience strong growth during the forecast period, with a compound annual growth rate (CAGR) of 5.01% through 2030. The market is expanding rapidly, driven by increasing awareness of substance abuse, ongoing advancements in testing technologies, and a growing demand for discreet, at-home screening options. These self-administered test kits offer users a private and convenient method to monitor drug use, eliminating the need for clinical visits. The demand for such solutions is particularly strong among individuals who value confidentiality in drug testing.

Despite the market's positive growth trajectory, concerns about the accuracy and reliability of at-home testing kits remain. Issues such as variations in testing methods, improper sample collection, and limited detection capabilities can result in inconsistent test results, leading to false positives or negatives. These inaccuracies can have serious consequences, especially for individuals undergoing rehabilitation or involved in legal proceedings. In response, manufacturers are focusing on enhancing test precision, improving sample collection processes, and expanding the range of detectable substances to enhance the credibility and usefulness of at-home DOA testing.

Key Market Drivers:

Prevalence of Substance Abuse: The widespread misuse of illicit and prescription drugs has created an increasing demand for frequent drug testing. In 2021, approximately 1 in 17 individuals aged 15-64 globally reported using a drug in the past year. The number of drug users rose from 240 million in 2011 to 296 million in 2021, accounting for 5.8% of the global population in this age group-a 23% increase. This trend has been driven in part by population growth and changing substance use patterns. The opioid crisis, particularly in North America, along with the growing legalization of cannabis in various regions, has raised concerns regarding workplace productivity, driving safety, and adolescent health. Additionally, the rising consumption of synthetic drugs, including methamphetamines and fentanyl analogs, has created a pressing need for cost-effective and rapid drug testing solutions. As a result, consumers and organizations are increasingly turning to at-home drug testing kits to identify substance use early and inform intervention or treatment decisions.

Key Market Challenges:

Accuracy and Reliability: Inaccurate test results, including false positives (indicating drug use when there is none) and false negatives (failing to detect drug use), can have significant consequences. These errors may lead to unnecessary panic or complacency, potentially undermining the credibility of at-home testing kits. If these tests are perceived as unreliable, consumers may lose confidence in the results, leading to reduced adoption rates. Inaccurate results can also influence critical decisions, such as treatment options or behavior changes, and may negatively impact legal cases or employment decisions. Unreliable test results can also harm the reputation of specific brands or the broader at-home drug testing market, resulting in negative word-of-mouth and potentially leading to stricter regulatory scrutiny. Ensuring consistent accuracy across various brands and batches presents an ongoing challenge for manufacturers, with quality control issues potentially affecting consumer perception.

Key Market Trends:

Advancements in Multi-Panel Testing Kits: Multi-panel testing kits, which detect multiple substances in a single test, are gaining traction due to their convenience and cost-effectiveness. By allowing users to screen for multiple drugs at once, these kits save time and reduce the need for separate tests. This efficiency is encouraging broader adoption and market growth. Moreover, multi-panel kits are often more affordable than purchasing individual tests for each drug, further boosting their popularity. These kits cover a wider range of substances, including common drugs of abuse and emerging drugs, thus meeting the diverse needs of users. They are especially appealing to parents concerned about their children's potential drug use, as well as to legal and clinical professionals who require more comprehensive information to make informed decisions. Public health campaigns promoting comprehensive drug testing align with the growing trend of multi-panel kits, further contributing to their widespread adoption.

Key Market Players

• Abbott Laboratories Inc.
• Dragerwerk AG & Co. KGaA.
• UCP Biosciences Inc.
• Orient New Life Medical Co. Ltd.
• Assure Tech. (Hangzhou) Co., LTD
• Psychemedics Corporation
• Confirm Biosciences Inc
• Pharmatech Inc.
• Atlas Medical GmbH
• Home Health (U.K.) Ltd

Report Scope:

In this report, the Global At-Home Drug of Abuse Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

At-Home Drug of Abuse Testing Market, By Sample Type:

• Urine Test
• Saliva Test
• Blood test
• Others

At-Home Drug of Abuse Testing Market, By Product Type:

• Drug Testing Kit
• Strips/Dip Cards
• Cassettes
• Cups
• Others

At-Home Drug of Abuse Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global At-Home Drug of Abuse Testing Market.

Available Customizations:

Global At-Home Drug of Abuse Testing market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global At-Home Drug of Abuse Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 5.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 5.2.3. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
  • 5.2.4. By Company (2024)
• 5.3. Market Map
• 5.3.1 By Sample Type
• 5.3.2 By Product Type
• 5.3.3 By Region

6. North America At-Home Drug of Abuse Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 6.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States At-Home Drug of Abuse Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Sample Type
      • 6.3.1.2.2. By Product Type
  • 6.3.2. Canada At-Home Drug of Abuse Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Sample Type
      • 6.3.2.2.2. By Product Type
  • 6.3.3. Mexico At-Home Drug of Abuse Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Sample Type
      • 6.3.3.2.2. By Product Type

7. Europe At-Home Drug of Abuse Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 7.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France At-Home Drug of Abuse Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Sample Type
      • 7.3.1.2.2. By Product Type
  • 7.3.2. Germany At-Home Drug of Abuse Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Sample Type
      • 7.3.2.2.2. By Product Type
  • 7.3.3. United Kingdom At-Home Drug of Abuse Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Sample Type
      • 7.3.3.2.2. By Product Type
  • 7.3.4. Italy At-Home Drug of Abuse Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Sample Type
      • 7.3.4.2.2. By Product Type
  • 7.3.5. Spain At-Home Drug of Abuse Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Sample Type
      • 7.3.5.2.2. By Product Type

8. Asia-Pacific At-Home Drug of Abuse Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 8.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China At-Home Drug of Abuse Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Sample Type
      • 8.3.1.2.2. By Product Type
  • 8.3.2. India At-Home Drug of Abuse Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Sample Type
      • 8.3.2.2.2. By Product Type
  • 8.3.3. Japan At-Home Drug of Abuse Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Sample Type
      • 8.3.3.2.2. By Product Type
  • 8.3.4. South Korea At-Home Drug of Abuse Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Sample Type
      • 8.3.4.2.2. By Product Type
  • 8.3.5. Australia At-Home Drug of Abuse Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Sample Type
      • 8.3.5.2.2. By Product Type

9. South America At-Home Drug of Abuse Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 9.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil At-Home Drug of Abuse Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Sample Type
      • 9.3.1.2.2. By Product Type
  • 9.3.2. Argentina At-Home Drug of Abuse Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Sample Type
      • 9.3.2.2.2. By Product Type
  • 9.3.3. Colombia At-Home Drug of Abuse Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Sample Type
      • 9.3.3.2.2. By Product Type

10. Middle East and Africa At-Home Drug of Abuse Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Sample Type (Urine Test, Saliva Test, Blood test and Others)
  • 10.2.2. By Product Type (Drug Testing Kit, Strips/Dip Cards, Cassettes, Cups and Others)
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa At-Home Drug of Abuse Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Sample Type
      • 10.3.1.2.2. By Product Type
  • 10.3.2. Saudi Arabia At-Home Drug of Abuse Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Sample Type
      • 10.3.2.2.2. By Product Type
  • 10.3.3. UAE At-Home Drug of Abuse Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Sample Type
      • 10.3.3.2.2. By Product Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Global At-Home Drug of Abuse Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Abbott Laboratories Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Product & Service Offerings
  • 15.1.3. Recent Developments
  • 15.1.4. Financials (If Listed)
  • 15.1.5. Key Personnel
  • 15.1.6. SWOT Analysis
• 15.2. Dragerwerk AG & Co. KGaA.
• 15.3. UCP Biosciences Inc.
• 15.4. Orient New Life Medical Co. Ltd.
• 15.5. Assure Tech. (Hangzhou) Co., LTD
• 15.6. Psychemedics Corporation
• 15.7. Confirm Biosciences Inc
• 15.8. Pharmatech Inc.
• 15.9. Atlas Medical GmbH
• 15.10. Home Health (U.K.) Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer